The cluster is small in scale and lacks insider corroboration. Monitor upcoming Q4 2026 13F filings to see if these additions were maintained or reversed, and watch for any catalyst (pipeline update, partnership) that could explain the buying.
OMER drugs
OMER drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $16.92entry
- T+1 · 8d ago +3.72%α +1.36% · $17.55
- T+5 · 4d ago +3.37%α +0.77% · $17.49
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Three institutional investors doubled or added to OMER positions in Q3 2026, with aggregate buying of $2.2M, while one seller trimmed a small stake. The cluster is small in dollar terms relative to the $1.3B market cap, and the 45-day reporting lag reduces timeliness. No insider buying corroborates the signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: $2.2M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Simplex Trading | DOUBLED | +164.9% | $447.0K | $363.0K |
| Creative Planning | ADD | +35.1% | $599.0K | $378.0K |
| Barclays | DOUBLED | +110.7% | $1.9M | $1.4M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Pictet Asset Management Holding | TRIM | -28.5% | $171.0K | -$74.0K |
Key Facts
- 3 buyers (Simplex Trading, Creative Planning, Barclays) added $2.2M in net new positions during Q3 2026
- 1 seller (Pictet Asset Management) trimmed $74K, a minor reduction
- Total buyer holdings rose to $2.9M from $0.7M prior quarter
- No open-market insider buying; insider-institutional confluence score is 4/100 (divergent)
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
Financial Impact
3 institutions accumulated $2.2M in new OMER positions while 1 reduced holdings by $74K; net buying of $2.1M represents ~0.16% of market cap
Risk Factors
- 13F data is stale by 45+ days; the cluster may have been unwound
- No insider buying to confirm the institutional thesis
- Total buying is modest relative to market cap, limiting price impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-OMER-2026-Q3 |
Track record
12 reports on OMER
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +98.11% at T+60 after the Jul 20, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Viewing Entry $16.92 settles Feb 4
- Oct 30, 202617d ago 8-K Neutral 3/10 Entry $17.83 settles Jan 29
- Sep 1, 202610w ago Insider Cluster Neutral 2/10 Entry $18.86 settles Nov 27
- Aug 28, 202611w ago Insider Cluster Neutral Not scored Entry $18.79 settles Nov 24
- Aug 25, 202611w ago Insider Cluster Neutral 3/10 Entry $18.22 settles Nov 19
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $19.32 settles Nov 17
- Jul 20, 202617w ago 8-K Bullish 5/10 Entry $9.53 to $18.88 ▲ +98.11% +94.14% vs SPY
- Jul 6, 202619w ago 8-K Neutral 4/10 Entry $10.34 to $19.25 ▲ +86.17% +84.45% vs SPY
- Jun 18, 202621w ago 8-K Bullish 5/10 Entry $10.28 to $17.46 ▲ +69.84% +67.95% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 4/10 Entry $10.18 to $18.95 ▲ +86.15% +81.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers